ARTNet Podcast
af NCI ARTNet
Resistance Before Treatment Begins: Why Some Tumors Are Already…
Om denne podcast
ARTNet Podcast is the official podcast of the National Cancer Institute (NCI) Acquired Resistance to Therapy Network (ARTNet). The series features conversations with leading cancer researchers who are advancing our understanding of why cancers resist treatment and how those mechanisms can be overcome. Through accessible discussions, each episode explores emerging discoveries in tumor biology, the tumor microenvironment, metabolism, immunology, and precision medicine, while highlighting the collaborative, team-science approach driving innovation across the ARTNet consortium. Designed for researchers, clinicians, trainees, patients, advocates, and the broader public, the podcast translates cutting-edge science into engaging conversations that illuminate the future of cancer therapy.
Episoder
- Resistance Before Treatment Begins: Why Some Tumors Are Already Primed to Survive · 43 min. · Episode 2Featuring Vlad Sandulache Associate Professor, Baylor College of Medicine MPI, ARTNet H-CARR U 54 Center Dr. Sandulache is a clinician-scientist studying head and neck cancer…
- Why Cancer Fights Back: A Conversation with Jeffrey Tyner · 35 min.Featuring Jeffrey Tyner Professor, Oregon Health & Science University Principle Investigator, ARTNet AML U54 Center Dr. Tyner is a leading researcher in cancer biology and…








